Zydus Lifesciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zydus Lifesciences has informed the exchanges that its trading window will remain closed from October 1, 2025 until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2025. The closure applies to directors, designated persons, and their immediate relatives, in line with the company's Code of Insider Trading and SEBI regulations. The board meeting date to approve these results will be communicated later. No financial figures have been disclosed in this filing.
This is a routine compliance announcement ahead of the upcoming Q2 FY26 earnings. It restricts insider trading during a sensitive period but carries no direct financial impact. Investors should watch for the upcoming board meeting date and results declaration, which could be a near-term catalyst for the stock.